RaySearch Laboratories Enhances Cancer Care in France
RaySearch Laboratories AB (publ) has exciting news as three significant cancer centers have chosen their innovative treatment planning system, RayStation. These centers, which include the Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have made their selections under the Unicancer 2019 Framework agreement.
What is Unicancer?
Unicancer is a prominent network of French hospitals that focuses exclusively on oncology. It comprises 18 comprehensive cancer centers in addition to two affiliated centers, all distributed across 22 hospitals. This extensive network provides treatment for over 600,000 patients each year, conducting 787 clinical trials in the process. The collective effort is aimed at advancing cancer treatment and research throughout the country.
Recent Developments and Financial Impact
The orders from the three centers were received during the summer, valued at approximately 3.2 million Euros, excluding service contracts. Significantly, one-third of this amount was recognized as revenue in the second quarter, while the remaining two-thirds were accounted for in the third quarter of the financial year.
Growing Adoption of RayStation
In total, 14 out of the 20 centers that are part of the Unicancer network, along with two public hospitals, have adopted RayStation as their treatment planning system under the current framework agreements that run for four years. Recent selections of RayStation and RayCare under a new Unicancer Framework agreement that came into effect in 2023 further solidify the system's reputation and usability in comprehensive care settings.
A Vision for Comprehensive Care
Johan Löf, the founder and CEO of RaySearch Laboratories, expressed his enthusiasm regarding these latest agreements. "I am very happy about the agreements with these important centers, especially since they are all comprehensive cancer centers. RayStation is an excellent starting point, but our vision is for our software to support all disciplines included in a comprehensive cancer center," Löf stated. His commitment underscores the company’s dedication to enhancing oncology care through advanced technology.
Regulatory Clearance Information
As a note, the use of RayStation may be subject to regulatory clearance in certain markets, indicating the need for compliance with local healthcare standards.
Looking Towards the Future
With these agreements, RaySearch Laboratories continues to strengthen its position in the oncology sector, providing essential tools that enhance patient care and treatment planning. As the landscape of cancer treatment evolves, the adoption of technology like RayStation is vital for better outcomes and more effective management of complex treatment plans.
Frequently Asked Questions
1. What is RayStation?
RayStation is a treatment planning system developed by RaySearch Laboratories, designed to facilitate sophisticated cancer treatment.
2. Which centers recently selected RayStation?
The Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges have recently chosen RayStation.
3. What is Unicancer?
Unicancer is a network of hospitals in France specialized in oncology, comprising multiple comprehensive cancer centers.
4. How much was the total order value from these cancer centers?
The total order value was approximately 3.2 million Euros, excluding service contracts.
5. What is the vision of RaySearch Laboratories for its software?
The vision is to support all disciplines involved in comprehensive cancer centers, enhancing the overall patient treatment experience.
